BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22578372)

  • 1. Use of point-of-care testing for plasma therapy.
    Goodnough LT; Hill CC
    Transfusion; 2012 May; 52 Suppl 1():56S-64S. PubMed ID: 22578372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma transfusion for bedside, radiologically guided, and operating room invasive procedures.
    Desborough M; Stanworth S
    Transfusion; 2012 May; 52 Suppl 1():20S-9S. PubMed ID: 22578367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices.
    Shephard MD; Mazzachi BC; Watkinson L; Shephard AK; Laurence C; Gialamas A; Bubner T
    Rural Remote Health; 2009; 9(3):1189. PubMed ID: 19689171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma transfusion for patients with severe hemorrhage: what is the evidence?
    Callum JL; Rizoli S
    Transfusion; 2012 May; 52 Suppl 1():30S-7S. PubMed ID: 22578369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point of care testing.
    Nichols JH
    Clin Lab Med; 2007 Dec; 27(4):893-908, viii. PubMed ID: 17950904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Algorithmic and consultative integration of transfusion medicine and coagulation: a personalized medicine approach with reduced blood component utilization.
    Brown RE; Dorion RP; Trowbridge C; Stammers AH; Fitt W; Davis J
    Ann Clin Lab Sci; 2011; 41(3):211-6. PubMed ID: 22075502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a multi-parameter Point-of-Care-blood test analyzer reduces central laboratory testing and need for blood transfusions in very low birth weight infants.
    Mahieu L; Marien A; De Dooy J; Mahieu M; Mahieu H; Van Hoof V
    Clin Chim Acta; 2012 Jan; 413(1-2):325-30. PubMed ID: 22056692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point of care testing in critical care.
    Schallom L
    Crit Care Nurs Clin North Am; 1999 Mar; 11(1):99-106. PubMed ID: 10373827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assuring quality in point-of-care testing: evolution of technologies, informatics, and program management.
    Lewandrowski K; Gregory K; Macmillan D
    Arch Pathol Lab Med; 2011 Nov; 135(11):1405-14. PubMed ID: 22032566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The need for a point of care testing: an evidence-based appraisal.
    Collinson PO
    Scand J Clin Lab Invest Suppl; 1999; 230():67-73. PubMed ID: 10389204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in utilization of intraoperative laboratory testing associated with the introduction of point-of-care testing devices in an academic department.
    Wax DB; Reich DL
    Anesth Analg; 2007 Dec; 105(6):1711-3, table of contents. PubMed ID: 18042871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of a comprehensive blood conservation program can reduce blood use in a community cardiac surgery program.
    Xydas S; Magovern CJ; Slater JP; Brown JM; Bustami R; Parr GV; Thurer RL
    J Thorac Cardiovasc Surg; 2012 Apr; 143(4):926-35. PubMed ID: 22285327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality in point-of-care testing.
    Nichols JH
    Expert Rev Mol Diagn; 2003 Sep; 3(5):563-72. PubMed ID: 14510177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical governance: implications for point-of-care testing.
    Freedman DB
    Ann Clin Biochem; 2002 Sep; 39(Pt 5):421-3. PubMed ID: 12227847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Point-of-care testing of hemostatic alterations in anaesthesia and intensive care].
    Calatzis A; Heesen M; Spannagl M
    Anaesthesist; 2003 Mar; 52(3):229-37. PubMed ID: 12666005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole blood and component use in resource poor settings.
    Marwaha N
    Biologicals; 2010 Jan; 38(1):68-71. PubMed ID: 20074978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fresh frozen plasma and platelet transfusion for nonbleeding patients in the intensive care unit: benefit or harm?
    Gajic O; Dzik WH; Toy P
    Crit Care Med; 2006 May; 34(5 Suppl):S170-3. PubMed ID: 16617262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study.
    Görlinger K; Dirkmann D; Hanke AA; Kamler M; Kottenberg E; Thielmann M; Jakob H; Peters J
    Anesthesiology; 2011 Dec; 115(6):1179-91. PubMed ID: 21970887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resuscitative strategies to maintain homeostasis during damage control surgery.
    Dutton RP
    Br J Surg; 2012 Jan; 99 Suppl 1():21-8. PubMed ID: 22441852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.